4//SEC Filing
Rovaldi Christopher 4
Accession 0001179110-18-005400
CIK 0001280600other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:41 PM ET
Size
7.3 KB
Accession
0001179110-18-005400
Insider Transaction Report
Form 4
Rovaldi Christopher
SVP, Program Mgmt and Ops
Transactions
- Sale
Common Stock
2018-04-03$39.02/sh−600$23,412→ 25,858 total - Sale
Common Stock
2018-04-03$38.27/sh−2,900$110,983→ 26,458 total
Footnotes (4)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.78 to $38.63 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- [F3]Includes 594 shares acquired pursuant to the Acceleron Pharma Inc. Employee Stock Purchase Plan on March 15, 2018.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $39.20 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
Documents
Issuer
ACCELERON PHARMA INC
CIK 0001280600
Entity typeother
Related Parties
1- filerCIK 0001706040
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:41 PM ET
- Size
- 7.3 KB